Skip to content

Clinical trials

Phase 1/2 Carcinoma, Renal Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1/2 Country / region: Belgium Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20162
20171
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Biosciences International Sàrl1
Mural Oncology, Inc1
Nektar Therapeutics1
Salubris Biotherapeutics Inc1
University Hospital, Antwerp1
University Hospital, Ghent1
iOmx Therapeutics AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell7
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms4
Melanoma4
Carcinoma, Transitional Cell3
Neoplasm Metastasis3
Squamous Cell Carcinoma of Head and Neck3
Triple Negative Breast Neoplasms3
Carcinoma, Hepatocellular2
Small Cell Lung Carcinoma2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.